Pope spends quiet first night in hospital, continues drug therapy and reads papers, Vatican says
Pope Francis slept well during a quiet first night in the hospital after being admitted with a respiratory tract infection, ...
STAT1d
Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Operational Efficiencies and Private Labels to Drive Near-Term Profit Growth for PPIH
Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...
Fierce Pharma1d
Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...
JD Supra2d
FDA Publishes Rule Updating ‘Healthy’ Nutrient Content Claim
On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
Another Food Recall? More Than 2 Million Donuts Just Got Pulled
More than 2 million donuts have been recalled due to Listeria risk—but many were sold under private-label brands like Dunkin' ...
Coya: A Few Catalysts On The Way For COYA-302 Makes This A Must Watch
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
BBC11d
Drug use
A recovering ketamine addict from Portsmouth warns of the drug's dangers as use soars among young people. The number treated across the region was an increase on the previous year. The early ...
THE WEEK15d
FDA approves painkiller said to thwart addiction
The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.
ConsumerAffairs15d
A new non-opioid pain medication wins Food and Drug Administration approval
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...